IFA reduced the capsular biosynthesis through altering bacterial metabolism. حسب Tingting Wang (123983)

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. حسب Tingting Wang (123983)

IFA disarmed capsule-mediated immune evasion. حسب Tingting Wang (123983)

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. حسب Tingting Wang (123983)

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. حسب Masashi Okawa (8951294)

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. حسب Tingting Wang (123983)

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. حسب Tingting Wang (123983)

Predictors in ordinal regression model for GDS. حسب Shane Naidoo (20148021)

"…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …"

Classification of hand grip strength. حسب Shane Naidoo (20148021)

"…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …"

Rating scale for functional severity [28]. حسب Shane Naidoo (20148021)

"…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …"

Regression model coefficients. حسب Shane Naidoo (20148021)

"…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …"

ICOPE screening positive participant’s responses. حسب Shane Naidoo (20148021)

"…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …"

WHO BMI classification for adults. حسب Shane Naidoo (20148021)

"…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …"

Histogram of the extracted parameters. حسب Qiuyu Du (20760848)

"…No significant associations were found with long-term outcomes.…"

S1 File - حسب Zsófia Tróznai (19923854)

"…Measurements of body size, body composition (InBody 720), and bone age were performed in all players who were selected to participate in the selection program (<i>n</i> = 264) (mean±sd age: 13.1±0.6 years) and in a sample of not-selected players (<i>n</i> = 266) (mean±sd age: 13.2±0.6 years). …"

Flowchart of the selection program. حسب Zsófia Tróznai (19923854)

"…Measurements of body size, body composition (InBody 720), and bone age were performed in all players who were selected to participate in the selection program (<i>n</i> = 264) (mean±sd age: 13.1±0.6 years) and in a sample of not-selected players (<i>n</i> = 266) (mean±sd age: 13.2±0.6 years). …"

Fig 5 - حسب Varun Tiwari (9258130)

Effect of DM, and/or <i>M. charantia</i> on the (I) number of corpuses lutea; (II) number of neonates, (III) weight of neonates; (IV) length of neonates levels in the control and d... حسب Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... حسب Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the neurotransmitters levels, acetylcholine (I) and dopamine (II). حسب Amoura M. Abou-El-Naga (21001524)